These British Association for Psychopharmacology guidelines cover the range and aims of
treatment for anxiety disorders. They are based explicitly on the available evidence and are …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

A consensus group consisting of 36 experts representing 20 leading German specialist
societies and patient self-help organizations developed evidence-based recommendations …

Background Anxiety disorders (panic disorder/agoraphobia, generalized anxiety disorder,
social phobia, and specific phobias) are the most common mental illnesses. For example …

To our knowledge, no previous meta-analysis has attempted to compare the efficacy of
pharmacological, psychological and combined treatments for the three main anxiety …

Given the enormous contribution of anxiety disorders to the burden of disease, it is key to
optimize their prevention and treatment. In this critical review we assess advances in the …

Objective To appraise the evidence for comparative efficacy and tolerability of drug
treatments in patients with generalised anxiety disorder. Design Systematic review of …

Abstract Starting in 2019, the 2014 German Guidelines for Anxiety Disorders (Bandelow et
al. Eur Arch Psychiatry Clin Neurosci 265: 363–373, 2015) have been revised by a …

Anxiety disorders, including panic disorder/agoraphobia (PDA), generalized anxiety
disorder (GAD), social anxiety disorder (SAD), and others, are the most prevalent mental …

Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …